Global Oncology Biosimilars Market to Grow at 29.87% CAGR by 2018

Global Oncology Biosimilars Market 2014-2018 is the latest addition to industry research reports collection.

This report covers the present scenario and the growth prospects of the Global Oncology Biosimilars market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales biosimilars used in cancer treatment.

Analysts forecast the Global Oncology Biosimilars market to grow at a CAGR of 29.87 percent over the period 2013-2018.

Single User License of the report is Available at US $2500

Global Oncology Biosimilars Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Oncology Biosimilars market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The report recognizes the following companies as the key players in the Global Oncology Biosimilars Market: Biocon Ltd., Celltrion Inc., Dr. Reddy's Laboratories Ltd., Hospira Inc., Mylan Inc. and Sandoz.

Other Prominent Vendors in the market are: 3SBio, Abbvie, AstraZeneca, BioXpress Therapeutics, Boehringer Ingelheim, Coherus Biosciences, Intas Pharmaceuticals, Merck Serono, Pfizer and Wockhardt.

Order a copy of this report at (Prices start at US $2500 for a single user PDF) .

One key trend in this market is the outsourcing of biosimilar manufacturing activities to developing countries. Outsourcing the manufacture of biosimilar products decreases the overall cost of manufacturing biosimilars, thereby making them affordable to patients.

According to the report, one of the main drivers of the market is the increase in the number of patent expiries. A number of biopharmaceutical patents are either about to expire in the near future or have already expired. This has helped propel the growth of vendors in the market.

Further, the report states that one of the major challenges that the market faces is the risk related to the failure of the drug in the market. The high investment required during the developmental stage of drugs creates risks for vendors.

Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Segmentation by Application
08. Geographical Segmentation
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
17. Key Vendor Analysis
18. Other Reports in this Series

List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Oncology Biosimilars Market 2013-2018 (US$ million)
Exhibit 3: Oncology Biosimilar Drug Segmentation by Application
Exhibit 4: Global Oncology Biosimilars Market by Geographical Segmentation 2013
Exhibit 5: Biocon: Business Segmentation by Revenue 2014
Exhibit 6: Biocon: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 7: Celltrion: Product Segmentation 2013
Exhibit 8: Global Oncology Biosimilars market: Business Segmentation by Revenue 2014
Exhibit 9: Global Oncology Biosimilars market: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
Exhibit 10: Dr. Reddy's Laboratories: Geographical Segmentation by Revenue 2014
View all 17 Exhibits

Have any Query on the Report get your Queries Resolved at .

About US: ( is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.